{"DataElement":{"publicId":"6438430","version":"1","preferredName":"HCT-CI Comorbidity Or Organ Impairment Disease or Disorder Present Type","preferredDefinition":"A description of the HCT-CI comorbidity or organ impairment disease or disorder that was present.","longName":"6438427v1.0:2737105v1.1","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"6438427","version":"1","preferredName":"HCT-CI Comorbidity Or Organ Impairment Disease or Disorder Present","preferredDefinition":"A tool that predicts overall mortality risk, as well as non-relapse mortality risk, for patients with hematologic malignancies following hematopoietic stem cell transplantation. The index considers 17 categories of organ dysfunction._The coexistence of two or more disease processes._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various tissues.  An organ is part of an anatomic system or a body region. Representative examples include the heart, lung, liver, spleen, and uterus._Loss or abnormality of psychological, physiological, or anatomic structure or function._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Being or existing in a specified place or at the specified time.","longName":"6438425v1.0:2233878v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"6438425","version":"1","preferredName":"Hematopoietic Cell Transplantation-Comorbidity Index Comorbidity Or Organ Impairment Disease or Disorder","preferredDefinition":"A tool that predicts overall mortality risk, as well as non-relapse mortality risk, for patients with hematologic malignancies following hematopoietic stem cell transplantation. The index considers 17 categories of organ dysfunction.:The coexistence of two or more disease processes.:An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various tissues.  An organ is part of an anatomic system or a body region. Representative examples include the heart, lung, liver, spleen, and uterus.:Loss or abnormality of psychological, physiological, or anatomic structure or function.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","longName":"6438425v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic Cell Transplantation-Comorbidity Index","conceptCode":"C155842","definition":"A tool that predicts overall mortality risk, as well as non-relapse mortality risk, for patients with hematologic malignancies following hematopoietic stem cell transplantation. The index considers 17 categories of organ dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Comorbidity","conceptCode":"C16457","definition":"The coexistence of two or more disease processes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Organ","conceptCode":"C13018","definition":"A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various tissues.  An organ is part of an anatomic system or a body region. Representative examples include the heart, lung, liver, spleen, and uterus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Impairment","conceptCode":"C21055","definition":"Loss or abnormality of psychological, physiological, or anatomic structure or function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76C8E29E-0EDC-2BF7-E053-F662850AA304","latestVersionIndicator":"Yes","beginDate":"2018-09-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-09-26","modifiedBy":"ONEDATA","dateModified":"2018-09-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233878","version":"1","preferredName":"Present","preferredDefinition":"Being or existing in a specified place or at the specified time.","longName":"C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F970CDF6-F829-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"76C8E29E-0EEA-2BF7-E053-F662850AA304","latestVersionIndicator":"Yes","beginDate":"2018-09-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-09-26","modifiedBy":"KUMMEROA","dateModified":"2020-01-30","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2737105","version":"1.1","preferredName":"Comorbidity Type","preferredDefinition":"The coexistence of two or more disease processes._Type; a subdivision of a particular kind of thing.","longName":"CMRBDTY_TP","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Diabetes","valueDescription":"Diabetes.","ValueMeaning":{"publicId":"2737106","version":"1","preferredName":"Diabetes.","longName":"2737106","preferredDefinition":"Requiring treatment with insulin or oral hypoglycemic drugs in the last 4 weeks but not diet alone.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495A4F7C-9111-4C68-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"COOPERM","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E72B-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Cardiac","valueDescription":"cardiac.","ValueMeaning":{"publicId":"2737107","version":"1","preferredName":"cardiac.","longName":"2737107","preferredDefinition":"Any history of coronary artery disease (one or more vessel-coronary artery stenosis requiring medical treatment, stent, or bypass graft), congestive heart failure, myocardial infarction, OR ejection fraction less than or equal to 50% on the most recent test.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495A4F7C-914B-4C68-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"KUMMEROA","dateModified":"2019-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E735-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Arrhythmia","valueDescription":"Arrhythmia.","ValueMeaning":{"publicId":"2737108","version":"1","preferredName":"Arrhythmia.","longName":"2737108","preferredDefinition":"Any history of atrial fibrillation or flutter, sick sinus syndrome, or ventricular arrhythmias requiring treatment.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495A4F7C-9170-4C68-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"COOPERM","dateModified":"2019-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E73F-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Solid tumor, prior","valueDescription":"Solid tumor, prior.","ValueMeaning":{"publicId":"2737115","version":"1","preferredName":"Solid tumor, prior.","longName":"2737115","preferredDefinition":"Solid tumor treated at any time point in the patient's history, excluding nonmelanoma skin cancer.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495AA903-837C-4AFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E749-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Renal, moderate / severe","valueDescription":"Renal, moderate / severe.","ValueMeaning":{"publicId":"2737117","version":"1","preferredName":"Renal, moderate / severe.","longName":"2737117","preferredDefinition":"Serum creatinine > 2 mg/dL or > 177 umol/L; on dialysis during the 4 weeks prior to transplant; OR prior renal transplantation.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495AA903-83C6-4AFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"KUMMEROA","dateModified":"2019-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E753-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Pulmonary, severe","valueDescription":"Pulmonary, severe.","ValueMeaning":{"publicId":"2737118","version":"1","preferredName":"Pulmonary, severe.","longName":"2737118","preferredDefinition":"Corrected diffusion capacity of carbon monoxide and/or FEV1 of less than or equal to 65% or dyspnea at rest attributed to pulmonary disease or the need for intermittent or continuous oxygen during the 4 weeks prior to transplant.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495AA903-83EB-4AFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"KUMMEROA","dateModified":"2019-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E75D-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Pulmonary, moderate","valueDescription":"Pulmonary, moderate.","ValueMeaning":{"publicId":"2737119","version":"1","preferredName":"Pulmonary, moderate.","longName":"2737119","preferredDefinition":"Corrected diffusion capacity of carbon monoxide and/or FEV1 of 66-80% or dyspnea on slight activity attributed to pulmonary disease at transplant.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495AA903-8410-4AFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"COOPERM","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E767-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Peptic ulcer","valueDescription":"Peptic ulcer.","ValueMeaning":{"publicId":"2737121","version":"1","preferredName":"Peptic ulcer.","longName":"2737121","preferredDefinition":"Any history of peptic (gastric or duodenal) ulcer confirmed by endoscopy or radiologic diagnosis requiring treatment.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495AA903-845A-4AFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"COOPERM","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E771-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Obesity","valueDescription":"Obesity.","ValueMeaning":{"publicId":"2737122","version":"1","preferredName":"Obesity.","longName":"2737122","preferredDefinition":"Patients older than 18 years with a body mass index (BMI) > 35 kg/m2 prior to the start of conditioning or a BMI of the 95th percentile or higher for patients aged 18 years or younger.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495AA903-847F-4AFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"KUMMEROA","dateModified":"2019-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E77B-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Inflammatory bowel disease","valueDescription":"Inflammatory bowel disease.","ValueMeaning":{"publicId":"2737123","version":"1","preferredName":"Inflammatory bowel disease.","longName":"2737123v1.00","preferredDefinition":"Any history of Crohn's disease or ulcerative colitis requiring treatment.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495AA903-84A4-4AFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"DWARZEL","dateModified":"2023-01-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E785-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Infection","valueDescription":"Infection.","ValueMeaning":{"publicId":"2737124","version":"1","preferredName":"Infection.","longName":"2737124","preferredDefinition":"Includes a documented infection, fever of unknown origin, or pulmonary nodules suspicious for fungal pneumonia or a positive PPD test requiring prophylaxis against tuberculosis. Patients must have started antimicrobial treatment before Day 0 with continuation of antimicrobial treatment after Day 0.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495AA903-84C9-4AFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"COOPERM","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E78F-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Hepatic, moderate / severe","valueDescription":"Hepatic, moderate / severe.","ValueMeaning":{"publicId":"2737125","version":"1","preferredName":"Hepatic, moderate / severe.","longName":"2737125","preferredDefinition":"Liver cirrhosis, bilirubin > 1.5 × upper limit of normal, or AST/ALT > 2.5 × upper limit of normal.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495AA903-84EE-4AFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"COOPERM","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E799-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Hepatic, mild","valueDescription":"Hepatic, mild.","ValueMeaning":{"publicId":"2737126","version":"1","preferredName":"Hepatic, mild.","longName":"2737126","preferredDefinition":"Bilirubin > upper limit of normal to 1.5 × upper limit of normal, or AST/ALT > upper limit of normal to 2.5 × upper limit of normal at the time of transplant OR any history of hepatitis B or hepatitis C infection.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495AA903-8513-4AFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"COOPERM","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E7A3-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Heart valve disease","valueDescription":"Heart valve disease.","ValueMeaning":{"publicId":"2737127","version":"1","preferredName":"Heart valve disease.","longName":"2737127","preferredDefinition":"At least a moderate to severe degree of valve stenosis or insufficiency as determined by Echo; prosthetic mitral or aortic valve; or symptomatic mitral valve prolapse.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495AA903-8538-4AFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"COOPERM","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E7AD-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Cerebrovascular disease","valueDescription":"Cerebrovascular disease.","ValueMeaning":{"publicId":"2737128","version":"1","preferredName":"Cerebrovascular disease.","longName":"2737128","preferredDefinition":"Any history of transient ischemic attack, subarachnoid hemorrhage or cerebral thrombosis, embolism, or hemorrhage.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495AA903-8573-4AFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"COOPERM","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E7B7-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E7C1-0EC3-E053-F662850AEE38","beginDate":"2008-06-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Psychiatric disturbance","valueDescription":"Psychiatric disturbance","ValueMeaning":{"publicId":"2751268","version":"1","preferredName":"Psychiatric disturbance","longName":"2751268","preferredDefinition":"Presence of any mood (e.g., depression), anxiety, or other psychiatric disorder (e.g. bipolar disorder or schizophrenia) requiring continuous treatment in the last 4 weeks.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DBF93E0-C3B0-0998-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-05-21","modifiedBy":"COOPERM","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E7CB-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Rheumatologic","valueDescription":"Rheumatologic (2)","ValueMeaning":{"publicId":"2590652","version":"1","preferredName":"Rheumatologic (2)","longName":"2590652","preferredDefinition":"Any history of a rheumatologic disease (e.g., systemic lupus erythematosis, rheumatoid arthritis, polymyositis, mixed connective tissue disease, or polymyalgia rheumatica, etc.) requiring treatment. (Do NOT include degenerative joint disease, osteoarthritis).","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"27CDB15B-105A-0A0D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-01-24","modifiedBy":"COOPERM","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E7D5-0EC3-E053-F662850AEE38","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"},{"value":"Prior malignancy","valueDescription":"Prior Malignant Neoplasm","ValueMeaning":{"publicId":"2774527","version":"1","preferredName":"Prior Malignant Neoplasm","longName":"2774527","preferredDefinition":"Earlier in time or order.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"545BF7ED-22A1-164E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"NYCHM","dateCreated":"2008-08-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"956FF73C-E7E0-0EC3-E053-F662850AEE38","beginDate":"2018-09-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ONEDATA","dateModified":"2019-10-21","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2737104","version":"1","preferredName":"Comorbidity Type","preferredDefinition":"The coexistence of two or more disease processes.:Type; a subdivision of a particular kind of thing.","longName":"C16457:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Comorbidity","conceptCode":"C16457","definition":"The coexistence of two or more disease processes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495A4F7C-90EB-4C68-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-26","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"SBREXT","dateModified":"2008-03-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"956FF73C-E715-0EC3-E053-F662850AEE38","latestVersionIndicator":"Yes","beginDate":"2008-03-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-21","modifiedBy":"ZHWENDY","dateModified":"2022-07-18","changeDescription":".","administrativeNotes":"7/18/2022: fixed the box symbol in VM definition.wz","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"PreTed_co_comorbid_org_imp_typ","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_CC_comorbid_org_imp_typ","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the HCT-CI comorbidi","type":"Preferred Question Text","description":"What was the HCT-CI comorbidity or organ impairment disease or disorder that was present?","url":null,"context":"NHLBI"},{"name":"Specify co-existing diseases or organ impairment","type":"Alternate Question Text","description":"Specify co-existing diseases or organ impairment","url":null,"context":"NHLBI"},{"name":"Specify co-existing diseases or organ impairment","type":"Application Standard Question Text","description":"Specify co-existing diseases or organ impairment","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"76C784A9-7785-626E-E053-F662850ACECE","latestVersionIndicator":"Yes","beginDate":"2018-09-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-09-26","modifiedBy":"KUMMEROA","dateModified":"2020-01-30","changeDescription":". System generated def displayed as alt def.; System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}